ArticleJournal of medical virology2020
Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19.
Article in Journal of medical virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.
- A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment.Scientific reports · 2020Pooled it
- Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis.International journal of antimicrobial agents · 2020Pooled it
- Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2022Review
- COVID-19 and the heart: what we have learnt so far.Postgraduate medical journal · 2021Review
- Imaging in COVID-19-related myocardial injury.The international journal of cardiovascular imaging · 2021Review
- Evaluation of retinotoxicity of COVID-19 treatment: Hydroxychloroquine and lopinavir/ritonavir.Journal of medical virology · 2021Article
- COVID-19 in children in Brunei Darussalam: Higher incidence but mild manifestations.Journal of medical virology · 2021Article
- COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays.Medicinal research reviews · 2021Review
- A case report of a rare cardiac complication in novel coronavirus disease.European heart journal. Case reports · 2020Article
- Perioperative pain management in COVID-19 patients: Considerations and recommendations by the Saudi Anesthesia Society (SAS) and Saudi Society of Pain Medicine (SSPM).Saudi journal of anaesthesiaArticle
- Prevalence of primary bacterial co-infections among patients with COVID-19 in Brunei Darussalam.Western Pacific surveillance and response journal : WPSARArticle
- Post-COVID-19 health-care utilization: one year after the 2020 first wave in Brunei Darussalam.Western Pacific surveillance and response journal : WPSARObservational
Corrections and comments
- Comment on
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.